NVAX

#2093
Novavax, Inc. - Common Stock
11.0 9 USD
+7.46%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
10.89
11.19
Year Range
6.13
11.97
Daily Change
+7.46%
Monthly Change
+38.45%
6 month change
+61.90%
Year Change
+56.64%
Previous Close
10.3 2
Open
10.9 4
Low
10.8 9
High
11.1 9
Volume
1 399
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Novavax, Inc. - Common Stock

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine.

News